Chronic urticaria (CU) is a debilitating skin disease affecting around 1% of the population.
CU can be subdivided into chronic spontaneous urticaria (CSU) and chronic inducible …

Aim This study aims to investigate the relationship between two novel inflammatory markers,
namely, the Systemic Inflammatory Response Index (SIRI) and the Systemic Immune …

Biomarkers that are able to predict the response to omalizumab (OMA) in chronic
spontaneous urticaria (CSU) are highly valued. The aim of our study was to evaluate the …

Purpose The aim of this study was to explore the relationship between non-alcoholic fatty
liver disease (NAFLD) and the two blood inflammatory markers including the systemic …

Abstract Background Omalizumab, an anti‐IgE monoclonal antibody, is an effective
treatment in chronic spontaneous urticaria (CSU). Predictors of fast and good response for …

Background Omalizumab is recommended as adjunctive therapy for antihistamine-refractory
chronic spontaneous urticaria (CSU). However, its long-term effectiveness is understudied …

Background Treating chronic urticaria (CU) that is unresponsive to H1-antihistamines
(H1AHs) is challenging, and the real-world effectiveness of omalizumab remains unclear …

Chronic spontaneous urticaria (CSU) is a relatively common dermatological disorder
characterized by sudden and unpredictable onset of pruritic wheals and/or angioedema, for …

The immune inflammatory response has an important role in urticaria. In this study, we
aimed to understand whether HALP score and systemic inflammatory response index (SII) …